PRE 14A

REXAHN PHARMACEUTICALS, INC PRE 14A 6-9-2014

Company: Opus Genetics, Inc.
Filed: March 28, 2014
Period of Report: June 9, 2014
Accession Number: 0001140361-14-014649

View Document ↗ View on SEC.gov ↗